✦ LIBER ✦

Team transference and resistance in the treatment of patients who act out

✍ Scribed by Peter L. Herschman

Publisher: Springer US
Year: 1972
Tongue: English
Weight: 972 KB
Volume: 46
Category: Article
ISSN: 0033-2720
DOI: 10.1007/bf01563447

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

What happened to the ones who dropped ou

What happened to the ones who dropped out? Outcome in eating disorder patients who complete or prematurely terminate treatment

✍ Tabita Björk; Caroline Björck; David Clinton; Staffan Sohlberg; Claes Norring 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

Long-acting injectable risperidone and m

Long-acting injectable risperidone and metabolic ratio: a possible index of clinical outcome in treatment-resistant schizophrenic patients

✍ Lucia Sara Volonteri; Giancarlo Cerveri; Ilaria Francesca De Gaspari; Maria Luis 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 173 KB

Identifying patients who require a chang

Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire

✍ A. J. Dowson; D. D’Amico; S. J. Tepper; V. Baos; F. Baudet; S. Kilminster 📂 Article 📅 2004 🏛 Springer Milan 🌐 English ⚖ 110 KB

Are antidepressants warranted in the tre

Are antidepressants warranted in the treatment of patients who present suicidal behavior?

✍ Michele Raja; Antonella Azzoni 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

## Abstract ## Objective The aim of the study was to ascertain the clinical course of patients admitted to a psychiatric intensive care unit (PICU) just after a suicide attempt (SA) and to evaluate the effectiveness of 2nd generation antipsychotics and mood stabilizers in these patients. ## Metho

A double-blind comparison of moclobemide

A double-blind comparison of moclobemide and amineptine in the treatment of depressed out-patients

✍ J. P. Macher; C. Mirabaud 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 131 KB

A double blind comparison of alprazolam,

A double blind comparison of alprazolam, diazepam and placebo in the treatment of anxious out-patients

✍ K. Davison; R. G. Farquharson; M. C. Khan; A. Majid 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 344 KB

The anxiolytic effects of alprazolam, a triazolobenzodiazepine, were evaluated in a double-blind 28-day comparison with diazepam and placebo in 46 out-patients suffering from anxiety states of moderate to severe intensity. Alprazolam 1.5-3 mg per day was found to be of at least equivalent anxiolytic